Genesis HealthCare Bankruptcy: Blocked Sale, New Buyer, and Residents

Genesis HealthCare, once the country’s largest nursing home operator, filed for Chapter 11 bankruptcy on July 9, 2025, in the U.S. Bankruptcy Court for the Northern District of Texas, and the case is still open. The company listed between $1 billion and $10 billion in assets and liabilities, faced nearly 1,000 injury and wrongful death lawsuits, and disclosed that unsecured creditors — including families holding settlements — “may get nothing.”¹ A first attempt to sell the company to an insider was blocked in December 2025; a new $1.02 billion buyer was selected in January 2026, and as of mid-2026 the sale has not yet closed.²

The filing covered Genesis HealthCare, Inc. and 298 affiliated entities under Case No. 25-80185, assigned to Judge Stacey G. Jernigan. At the time, Genesis ran 175 skilled nursing and assisted living facilities across 18 states and employed roughly 27,000 people.³ Secured debt totaled about $708.5 million; unsecured debt exceeded $1.5 billion, owed to pension funds, vendors, state governments, and families with legal settlements. The company obtained $30 million in debtor-in-possession financing, $8 million of it from Omega Healthcare Investors, and said the filing was meant to resolve “legacy liabilities associated with previously divested operations.”⁴

How Genesis Got Here

The debt problem traces to 2007, when private equity firms Formation Capital and JER Partners took Genesis private in a $1.7 billion leveraged buyout, financed largely with debt placed on the company’s own books.⁵ In 2011, the owners sold 147 Genesis real estate properties to Health Care REIT (now Welltower) for $2.4 billion, turning Genesis into a tenant under long-term triple-net leases responsible for rent, taxes, insurance, and maintenance. Proceeds went to investors rather than into the facilities.⁶

By 2021, Genesis was again close to bankruptcy. Joel Landau’s firm ReGen Healthcare, affiliated with Pinta Capital Partners, put in $100 million for a 93% equity stake and two board seats. Genesis delisted from the NYSE that March and moved to the OTC Pink Sheets, ending its SEC reporting.⁷ ReGen added $25 million in 2023 for a third board seat, and by 2024 Landau’s WAX Dynasty Partners had assumed over $50 million of Genesis debt.⁶ Under ReGen’s management, the share of Genesis facilities rated four or five stars by CMS fell from 38% to 15%, and the company’s average facility rating dropped from 2.98 to 2.29 stars.¹

What It Means for Families With Settlements and Lawsuits

At filing, Genesis faced nearly 1,000 pending and settled lawsuits tied to patient injuries and deaths, with estimated liability of $259 million.⁸ The company had been spending about $8 million a month on legal defense and settlements.⁵

A joint investigation by KFF Health News and CBS News found that Genesis had a pattern of signing settlement agreements and then using contract provisions to defer payments, often for a year or more. Of 155 settlement agreements reviewed, Genesis had paid nothing in 85 and only partial amounts in 70, leaving $41 million of the $58 million it had promised still unpaid at the filing date.⁹ Individual cases show what that looks like:

A $3.5 million wrongful death settlement for Nancy Hunt, signed in August 2024, with $1.4 million still owed.
A $650,000 wrongful death settlement for Nellie Betancourt, agreed in April 2025, on which Genesis filed for bankruptcy before the first installment was due.
A $3 million neglect settlement for the estate of Alma Brown, on which Genesis stopped payments after $1 million and declared bankruptcy the day a judge ordered fines for non-payment.
A $925,000 settlement for sexual assault, in the R.S. case, with nothing paid.⁸

The bankruptcy filing automatically stayed all pending litigation. Personal injury claims are unsecured, and in Chapter 11, secured creditors are paid before unsecured ones. Genesis’s chief restructuring officer acknowledged that unsecured creditors “may get nothing” from more than $1.6 billion in claims.¹ The general deadline to file a proof of claim was October 31, 2025; the governmental bar date was January 5, 2026. Both have passed.²

The Blocked Insider Sale

When Genesis filed, it arranged a “stalking horse” bid from CPE 88988 LLC, an entity controlled by Joel Landau through WAX Dynasty Partners, to buy substantially all of the company’s assets. The proposed deal would have kept all 175 facilities operating and preserved employment for 27,000 workers, but it also included provisions releasing Landau, associate David Gefner, Pinta Capital Partners, and related entities from personal liability for claims against Genesis.¹⁰ Internal Genesis documents indicated that the company chose to file in Texas because of the Northern District’s “favorable case law on releases and insider transactions.”¹

Senators Elizabeth Warren, Richard Blumenthal, and Peter Welch, along with Representative Maggie Goodlander, sent Genesis a demand for information in October 2025, and on December 8, 2025, Warren, Blumenthal, and Goodlander filed an amicus brief urging the court to appoint an independent examiner.¹¹ The U.S. Trustee’s office also opposed the proposed insider sale.

In December 2025, Judge Jernigan refused to approve it, citing “too many irregularities” in the auction, including the exclusion of certain bidders and the undervaluing of competing offers. She said she could not approve any sale with liability releases for Landau and Gefner without Landau first testifying under oath about his good faith, and ordered the auction redone under the U.S. Trustee’s supervision.⁹

The New Buyer

On January 7, 2026, Judge Jernigan approved Genie 3 Partners LLC as a new stalking horse bidder, with an offer of nearly $1 billion made up of $259 million in cash, a $100 million unsecured promissory note, and the assumption of significant liabilities. Genie 3 received a $10 million break-up fee.¹²

The redone auction took place on January 14, 2026. After five rounds, 101 West State Street LLC was selected with an offer of about $1.02 billion — $343 million in cash, a $100 million promissory note, and the assumption of $572 million in liabilities. Genie 3 became the backup bidder at $991 million.¹³¹⁴ A sale approval hearing was scheduled for January 20, 2026.

The U.S. Trustee’s office then moved to install an independent Chapter 11 trustee, arguing Genesis management had conflicts of interest. On January 29, 2026, Judge Jernigan denied that motion, finding the evidence did not meet the threshold and that appointing a trustee would be disruptive, add administrative cost, and risk triggering the buyer’s termination rights.¹⁵

In March 2026, Genesis and the unsecured creditors committee filed an adversary proceeding inside the bankruptcy to block repayment of roughly $96 million in secured term loans held by Landau- and Gefner-controlled entities Wax Dynasty Partners and MAO 22322, alleging the debt was acquired with “actual intent to hinder, delay, or defraud” other creditors. Landau and Gefner moved to dismiss in April 2026, calling the transactions legitimate; that motion remained pending.¹⁶¹⁷

Effect on Residents and Facilities

Individual facilities have been affected. Genesis’s last remaining nursing home in Connecticut was set to close in August 2025 after residents were evacuated over Legionella contamination and fire safety concerns.¹⁸ In September 2025, CMS moved to close Magnolia Ridge in Alabama for failing to meet Medicare and Medicaid health and safety requirements, and Genesis filed an emergency motion to block decertification.¹ Three Patient Care Ombudsmen were appointed by the court to monitor conditions during the case.²

Pennsylvania, which hosts the largest share of Genesis facilities, filed a $58 million claim against the company for unpaid provider taxes. Governor Josh Shapiro said “private equity should get out of the nursing facility business in Pennsylvania,” and the state Department of Human Services described Genesis as having been “bled dry by greed and mismanagement.”¹⁸

Where the Case Stands

As of mid-2026, Genesis remains in Chapter 11 with no confirmed reorganization plan. A notice of a renewed sale auction and hearing has been filed, meaning the January 2026 sale to 101 West State Street LLC has not yet closed.² The claims bar dates have passed. The adversary proceeding over the $96 million in Landau- and Gefner-linked loans remains pending. Genesis shares still trade on the OTC Pink Sheets at essentially zero, with a listed market capitalization of about $17,800.⁷ Families holding unpaid settlements remain unsecured creditors, and the ultimate recovery for that group depends on what proceeds from a completed sale, after secured debt and administrative costs, are left to distribute.

1
U.S. Senate. Congressional Letter on Genesis Healthcare Bankruptcy
2
Epiq. Genesis Healthcare Bankruptcy Case Information
3
Skilled Nursing News. Skilled Nursing Giant Genesis Healthcare Files for Chapter 11 Bankruptcy
4
Genesis HealthCare. Genesis HealthCare Announcement
5
Private Equity Stakeholder Project. Genesis Healthcare Files for Bankruptcy
6
Center for Economic and Policy Research. Inside the Genesis Private Equity Bankruptcy Case
7
Simply Wall St. Genesis Healthcare
8
CBS News. Genesis Nursing Home Bankruptcy Settlements
9
KFF Health News. Genesis Bankruptcy Judge Ruling on Delayed Settlement Payments
10
U.S. Senate. Genesis Healthcare Amicus Brief
11
U.S. Senate. Warren, Blumenthal, Goodlander File Amicus Brief Pushing for Independent Examiner
12
Bloomberg Law. Genesis Healthcare Approved to Restart Auction With New Lead Bid
13
Bisnow. Genesis Healthcare Chooses $1B Bid in Bankruptcy Auction
14
Vista Today. Genesis Healthcare Bankrupt Sale
15
McKnight’s Long-Term Care News. Judge Rejects Attempt to Bump Genesis From Its Own Bankruptcy Case Over Alleged Conflicts of Interest
16
McKnight’s Long-Term Care News. Inside Genesis: Investors Fight for Repayment
17
Bloomberg Tax. Genesis Healthcare Investors Fight Suit to Cancel Secured Debts
18
Skilled Nursing News. Nursing Home Giant Genesis Bankruptcy Puts Private Equity Ownership Under Scrutiny